{
  "id": 8059963,
  "title": "Why HaloMD became a target — and what its top lobbyist says critics get wrong",
  "url": "https://urgent.news/2026/09/17/why-halomd-became-a-target-and-what-its-top-lobbyist-says-critics-get",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T16:21:16.000Z",
  "source": {
    "name": "Healthcare Dive",
    "slug": "healthcare-dive",
    "url": "https://www.healthcaredive.com/news/halomd-lobbyist-velliky-interview-no-surprises-idr-criticism/830321/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Patrick Velliky is confident the No Surprises Act is lowering out-of-network spending, despite research to the contrary. HaloMD’s chief external affairs officer responds to criticisms of his analysis, and of his company.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}